The Remarkable Versatility of GLP-1 Drugs: Unlocking Treatments for Obesity, Parkinson’s, Heart Failure, and Beyond
The excitement surrounding the GLP-1 family of drugs continues to build, and for good reason. These versatile medications are proving to be game-changers across a range of diseases, far beyond their initial approval for treating diabetes. Perhaps most notably, GLP-1 drugs have unlocked new possibilities for addressing the epidemic of obesity. As the author notes, …